Health Care Select Sector SPDR
Find Ratings Reports- Last Ratings Update:02/29/2024
- Price as of 02/29/2024 :$144.82
- Net Assets:$0 Million
- NAV:$146.3
- Premium-1.01%
- Peer Rank:7 of 48
- Investment Rating:B
- Performance:B
- RiskC+
We rate Health Care Select Sector SPDR at B. Positive factors that influence this rating include a well above average total return, low price volatility, low expense structure and long term portfolio management tenure. The fund invests approximately 100% of its assets in stocks and may be considered for investors seeking a Sector - Health/Biotechnology strategy.
Total return ranks very high in comparison with peers over the last three years. The Health Care Select Sector SPDR has returned an annual rate of 8.79% since inception. More recently, the fund has generated a total return of 11.90% in the last five years, 10.69% in the last three years, and 15.18% in the last year. How does that compare to other equity funds? In the last five years, it has outperformed 84% of them. It has also outpaced 85% of its competitors on a three year basis and 67% of them over the last year for the period ending 2/29/2024. On a year to date basis, XLV has returned 7.30%.
Downside risk has been below average. XLV has a draw down risk of -14.04%, which is the largest price decline experienced over the last three years. This fund has a three year standard deviation of 14.7%. This fund has had moderate volatility in its monthly performance over the last 36 months.
Low expense ratio helps performance. As XLV is an exchange traded fund, it has no front end or back end load.
The Health Care Select Sector SPDR is managed by Michael J. Feehily at SSgA Funds Management Inc. This fund is one of 128 SSgA Funds Management Inc exchange-traded funds launched since 1/22/1993 that we track.